首页> 外国专利> METHOD FOR TREATMENT OF DISEASES CAUSED AND ACCOMPANYING DISTURBANCE IN METABOLISM OF BILE ACIDS AND CHOLESTEROL

METHOD FOR TREATMENT OF DISEASES CAUSED AND ACCOMPANYING DISTURBANCE IN METABOLISM OF BILE ACIDS AND CHOLESTEROL

机译:处理胆汁酸和胆固醇代谢中引起的疾病和伴随疾病的方法

摘要

FIELD: medicine, gastroenterology, medicinal biochemistry.;SUBSTANCE: invention relates to a method for treatment and choice of a pharmaceutical preparation used in treatment of diseases caused and accompanying with disturbance in metabolism of bile acids and cholesterol. Method involves determination of the quantitative composition of short-chain fatty acids of (C2-C4)-fraction in blood serum and feces. Method involves using preparations containing fatty acids and promoting fro dissolving cholesterol bile stones in case when the content of propionic acid is decreased from 5.6% and increasing the content of butyric acid from 3.5%, and in increasing propionic acid from 19.9% to 21.8% and butyric acid from 18.9% to 20.1% in feces. Method involves administration of preparations effecting on activity of intestine anaerobic microorganisms in case when the content of propionic acid is decreased from 5.7% to 6.5% and the content of butyric acid is increased from 2.9% to 3.4% in blood serum, and when the content of propionic acid is increased from 21.8% and that of butyric acid from 20.1% in feces. Method involves the combination of preparations containing fatty acids and promoting to dissolving cholesterol bile stones and preparations effecting on activity intestine anaerobic microorganisms when the content of propionic acid is decreased from 5.6% and less and the content of butyric acid is increased from 3.5% and above. Proposed method provides possibility for differentiating treatment based on assay of leading ethiopathogenetic mechanisms in development of choledocholithiasis.;EFFECT: improved and enhanced method of treatment.;2 tbl, 3 ex
机译:用于治疗和选择胆汁酸和胆固醇代谢紊乱引起的疾病的药物制剂的方法和选择本发明涉及一种用于治疗和选择用于治疗由胆汁酸和胆固醇代谢紊乱引起的疾病的药物制剂的方法和选择。该方法涉及测定血清和粪便中(C 2 -C 4 )馏分的短链脂肪酸的定量组成。该方法包括在丙酸含量从5.6%降低,丁酸含量从3.5%升高,丙酸含量从19.9%增加到21.8%的情况下,使用含脂肪酸的制剂并促进胆固醇胆固醇的溶解。粪便中的丁酸含量从18.9%降至20.1%。该方法涉及在血清中丙酸的含量从5.7%降低至6.5%,丁酸的含量从2.9%升高至3.4%的情况下以及当血清中丙酸的含量从肠内厌氧微生物的活性给药的制剂粪便中丙酸的含量从21.8%增加,丁酸的含量从20.1%增加。该方法涉及将含有脂肪酸并促进溶解胆固醇的胆汁结石的制剂与当丙酸的含量从5.6%以下减少并且将丁酸的含量从3.5%以上增加时对活性肠厌氧微生物有影响的制剂组合使用。拟议的方法为基于胆总管结石病发展过程中主要的致病性致病机制的分析提供了区分治疗的可能性。效果:改进和增强的治疗方法。2 tbl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号